Abbas Sahili

Abbas Sahili is an accomplished advisor and acting CEO at Singzyme since October 2022, where key contributions include being a founding team member and main co-inventor of core technology, drafting the initial business plan, and successfully leading fundraising efforts. Since October 2015, Abbas Sahili has served as a Senior Research Fellow at Nanyang Technological University, Singapore, leading research teams and authoring over 10 scientific papers focused on protein ligases and structural virology. Prior experience includes a role as Principal Scientist at Epitoire and a Ph.D. student at the Institute for Integrative Biology of the Cell, with a thesis centered on protein function and virulence. Educational qualifications comprise a Research Doctorate from Paris-Sud University and multiple degrees from Université de Lorraine, specializing in biochemistry and protein engineering.